Alvocade® (Bortezomib) Safety and Effectiveness Study

Clinical trial NCT06012383 · COMPLETED

Trial details

NCT number: NCT06012383
Sponsor: NanoAlvand
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma, Refractory

Start date: 2016-07-01
Primary completion: 2022-12-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.